X-linked inhibitor of apoptosis (XIAP) deficiency is a rare primary immunodeficiency and gastrointestinal (GI) lesions in XIAP deficiency are similar to Crohn’s disease. For patients with Crohn’s disease, endoscopic balloon dilation (EBD) is known to be a standard procedure for intestinal strictures including upper GI tract. However, there are no articles which mention the efficacy of EBDs for the strictures in upper GI tract in patients with XIAP deficiency. Herein, we describe an 18-year-old male with XIAP deficiency in whom EBDs for the rectum, ileocecal valve (ICV), and duodenum were performed. Before hematopoietic stem cell transplantation (HSCT), GI endoscopy revealed strictures of the rectum, ICV and duodenum with active ulcers. Although these ulcers healed after HSCT, the strictures progressed. Therefore, we performed EBDs for the strictures of the rectum, ICV, and duodenum. In contrast studies, we did not find any other strictures in the small intestine. Throughout the patient’s clinical course, no complications of EBD occurred. He started eating after EBDs, but abdominal symptoms did not relapse without any dietary restrictions. Our case suggests that EBD could be an effective and safe procedure for intestinal strictures including upper GI tract after HSCT in patients with XIAP deficiency.
Inflammatory bowel disease (IBD) is an idiopathic, multi-etiological disease characterized by inflammation and mucosal destruction of the gastrointestinal tract. Despite the remarkable advance in immunomodulating therapies, there still remains a certain population of patients who are refractory to conventional as well as biologic therapies and fail to achieve mucosal healing. To improve the prognosis of those patients, at least 2 types of stem cells have been tested for their potential therapeutic use. Transplantation of hematopoietic stem cells or mesenchymal stem cells have been tested in several clinical studies, but their beneficial effect still remains controversial. In this review, we would like to overview the recent clinical challenges of stem cell-based therapies in IBD and also introduce our new therapeutic plan of intestinal stem cell transplantation for IBD, based on our ex vivo intestinal organoid culture technique.
Citations
Citations to this article as recorded by
Mesenchymal stem cell-derived exosomes as a plausible immunomodulatory therapeutic tool for inflammatory diseases Muhammad Zubair, Fatma A. Abouelnazar, Muhammad Asad Iqbal, Jingyun Pan, Xuwen Zheng, Tao Chen, Wenming Shen, Jinnan Yin, Yongmin Yan, Pengjun Liu, Fei Mao, Ying Chu Frontiers in Cell and Developmental Biology.2025;[Epub] CrossRef
Myths and Realities about the Private Sector Stem Cell Industry in Malaysia Kean Chang Phang, Mohammad Firdaus Bin Abdul Aziz Asian Bioethics Review.2025; 17(4): 729. CrossRef
Optimizing Wnt activation in fetal calf serum (FCS)-free organoid expansion media Esther J. M. Liefting, Jeffrey J. Bajramovic Frontiers in Toxicology.2025;[Epub] CrossRef
From bench to bedside: the role of gastrointestinal stem cells in health and disease Xiaopeng Bai, Eikichi Ihara, Yoshimasa Tanaka, Yosuke Minoda, Masafumi Wada, Yoshitaka Hata, Mitsuru Esaki, Haruei Ogino, Takatoshi Chinen, Yoshihiro Ogawa Inflammation and Regeneration.2025;[Epub] CrossRef
Cell-derived vesicles extruded from adipose mesenchymal stem cells attenuate intestinal inflammation and augment epithelial regeneration in a colitis model Min Kyoung Jo, Hyeon-Jeong Jeon, So Hui Kim, Hye Sun Lee, Seong-Eun Kim, Sung-Ae Jung, Hui-Chong Lau, Sung-Soo Park, Seung Wook Oh, Chang Mo Moon Nanoscale.2025; 17(47): 27337. CrossRef
The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitis Emma Ruysseveldt, Brecht Steelant, Tine Wils, Jonathan Cremer, Dominique M.A. Bullens, Peter W. Hellings, Katleen Martens Journal of Allergy and Clinical Immunology.2024; 154(3): 631. CrossRef
Cellular Plasticity in Gut and Liver Regeneration Minwook Kim, Yoojeong Park, You Sun Kim, Sungjin Ko Gut and Liver.2024; 18(6): 949. CrossRef
Revolutionizing medicine: recent developments and future prospects in stem-cell therapy Bashdar M. Hussen, Mohammad Taheri, Raya Kh. Yashooa, Gaylany H. Abdullah, Snur R. Abdullah, Ramiar Kamal Kheder, Suhad A. Mustafa International Journal of Surgery.2024; 110(12): 8002. CrossRef
Nigakinone alleviates DSS‐induced experimental colitis via regulating bile acid profile and FXR/NLRP3 signaling pathways Fangle Liu, Yufeng Yao, Qian Wang, Fengxue Zhang, Meiqi Wang, Chenchen Zhu, Chaozhan Lin Phytotherapy Research.2023; 37(1): 15. CrossRef
TNFα Induces LGR5+ Stem Cell Dysfunction In Patients With Crohn’s Disease Chansu Lee, Minae An, Je-Gun Joung, Woong-Yang Park, Dong Kyung Chang, Young-Ho Kim, Sung Noh Hong Cellular and Molecular Gastroenterology and Hepatology.2022; 13(3): 789. CrossRef
Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress Geonhee Han, Haeun Cho, Hyosuk Kim, Yeongji Jang, Hochung Jang, Da Eun Kim, Eun Sun Kim, Eun Hye Kim, Kwang Yeon Hwang, Kwangmeyung Kim, Yoosoo Yang, Sun Hwa Kim Biomaterials Science.2022; 10(8): 2076. CrossRef
The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer Gang Guo, Zhaobang Tan, Yaping Liu, Feiyu Shi, Junjun She Stem Cell Research & Therapy.2022;[Epub] CrossRef
Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases Zhengping Che, Ziyu Ye, Xueying Zhang, Bihua Lin, Weiqing Yang, Yanfang Liang, Jincheng Zeng Frontiers in Immunology.2022;[Epub] CrossRef
Mechanotransduction through adhesion molecules: Emerging roles in regulating the stem cell niche Ryan Lim, Avinanda Banerjee, Ritusree Biswas, Anana Nandakumar Chari, Srikala Raghavan Frontiers in Cell and Developmental Biology.2022;[Epub] CrossRef
Clinical applications and optimization of patient-derived organoids in intestinal diseases Tae Il Kim Organoid.2022; 2: e22. CrossRef
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases Jinsha Liu, Joey Paolo Ting, Shams Al-Azzam, Yun Ding, Sepideh Afshar International Journal of Molecular Sciences.2021; 22(6): 2805. CrossRef
Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn’s disease: a retrospective observational stud Min Young Park, Yong Sik Yoon, Jong Lyul Lee, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang, Chang Sik Yu Stem Cell Research & Therapy.2021;[Epub] CrossRef
Current Trends and Research Topics Regarding Intestinal Organoids: An Overview Based on Bibliometrics Meng-Meng Zhang, Ke-Lu Yang, Yan-Cheng Cui, Yu-Shi Zhou, Hao-Ran Zhang, Quan Wang, Ying-Jiang Ye, Shan Wang, Ke-Wei Jiang Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
The Potential of Vitamin D3 to Repaired Mucosal Injury in Dextran Sulfate Sodium Induced Acute Colitis in Mice Satrio Wibowo, Krisni Subandiyah, Kusworini Handono, Sri Poeranto Open Access Macedonian Journal of Medical Sciences.2021; 9(B): 931. CrossRef
Pharmacogenetics-based personalized treatment in patients with inflammatory bowel disease: A review Ji Young Chang, Jae Hee Cheon Precision and Future Medicine.2021; 5(4): 151. CrossRef
Mutual regulation between butyrate and hypoxia‐inducible factor‐1α in epithelial cell promotes expression of tight junction proteins Jiuheng Yin, Chao Zhou, Kunqiu Yang, Yanbei Ren, Yuan Qiu, Pengyuan Xu, Weidong Xiao, Hua Yang Cell Biology International.2020; 44(6): 1405. CrossRef
Letter: off‐label use of hyperbaric oxygen therapy in inflammatory bowel disease—Authors’ reply Melek Simsek, Nanne K. H. de Boer Alimentary Pharmacology & Therapeutics.2020; 52(1): 216. CrossRef
The Role of Immune and Epithelial Stem Cells in Inflammatory Bowel Disease Therapy Agata Binienda, Sylwia Ziolkowska, Ingvild H. Hauge, Maciej Salaga Current Drug Targets.2020; 21(14): 1405. CrossRef